Changes in myocardial collagen content before and after left ventricular assist device application in dilated

Hong Liang1, Johannes Müller, Yu-guo Weng

  • 1Department of Cardiovascular and Thoracic Surgery, Medical College of Jinan University, Guangzhou 510630, China. lianghong58@hotmail.com

Insights

Left ventricular assist device (LVAD) support in dilated cardiomyopathy (DCM) alters myocardial collagen fractions, not total collagen, influencing prognosis. These collagen changes indicate a reversal of maladaptive remodeling after LVAD implantation.

Area of Science:

  • Cardiology
  • Biochemistry
  • Biomedical Engineering

Background:

  • Dilated cardiomyopathy (DCM) involves significant myocardial interstitial remodeling.
  • Left ventricular assist devices (LVADs) are used to manage advanced DCM.
  • Understanding collagen changes post-LVAD is crucial for prognosis and treatment.

Purpose of the Study:

  • To confirm changes in myocardial collagen levels after LVAD support in DCM patients.
  • To correlate these collagen changes with patient prognosis.
  • To evaluate a practical method for assessing myocardial collagen levels.

Main Methods:

  • Left ventricular samples from DCM patients (transplanted and weaning groups) were analyzed pre- and post-LVAD implantation.
  • Collagen fractions (NSC, ASC, total, ISC) were quantified using Sircol assay and hydroxyproline.
  • Serum procollagen peptides (P I CP, P I NP, P III NP, I CTP) were measured via radioimmunoassay.

Main Results:

  • LVAD support altered specific collagen fractions, with differences observed between transplanted and weaning groups.
  • Myocardial collagen levels in the transplanted group normalized after LVAD support compared to the weaning group.
  • Serum procollagen peptide levels showed distinct patterns in transplanted versus weaning groups post-LVAD.

Conclusions:

  • Myocardial interstitial remodeling in DCM is characterized by changes in collagen fractions, not total collagen, and is linked to prognosis.
  • LVAD support can reverse maladaptive myocardial interstitial remodeling, as evidenced by collagen content and serum procollagen peptide changes.
  • These findings highlight the role of collagen remodeling in DCM and the therapeutic potential of LVADs.
Abstract